May 17, 2021 / 07:30PM GMT
Franklin Jarman - Goldman Sachs Group, Inc., Research Division - VP and Senior Analyst
Okay. Great. Let's go ahead and start our next presentation. So I am Frank Jarman, again, our high-yield technology analyst -- or sorry, high yield health care analyst here at Goldman Sachs. And I am very pleased to have Hologic here with us today. From Hologic, we have Michael Watts, who's Vice President of Investor Relations and Corporate Development; and Marci Lerner, who is Vice President and Treasurer of the company. So Michael and Marci, thank you both so much for joining us today. The Hologic team is going to start off with a couple of slides, and then we'll wrap up with some Q&A.
And with that, Michael, I will go ahead and pass the floor over to you.
Michael J. Watts - Hologic, Inc. - VP of IR & Corporate Communications
Yes. Thank you, Frank, and thanks to Goldman for having us. We're glad to be here.
Let me just reference Slide 2 to begin. That's our safe harbor statement. Obviously, we will be making some forward-looking statements this
Hologic Inc at Goldman Sachs Credit and Leveraged Finance Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers